introduCtion and early years
Hans Walter Kosterlitz will be remembered as the winner of an international race to identify the first endogenous opioid, enkephalin. He came to the UK from Berlin in 1934, one of the many scientific émigrés of that period who later so enriched biochemistry, physiology and pharmacology. His entire career was spent at the University of aberdeen, where he developed a reputation first in carbohydrate metabolism and later in the pharmacology of opiates. His strong experimental skills, and particularly the use of bioassays on tissues from laboratory animals, allowed him to predict the effectiveness and abuse potential of opiate drugs. Most notably, this led to the isolation of the peptide hormone enkephalin, the first of a group of such peptides now often known as endorphins. this work was done in his seventies, after his official retirement, with an energy and enthusiasm that could leave younger colleagues physically tired but intellectually stimulated.
the Kosterlitz family can be traced to langendorf (now Weilowies) in Grosse strelitz (now strzelce opolskie), a region of Upper silesia. the region was originally within Poland (at the end of the tenth century), and was subsequently under the rule of the Bohemia (since 1327), the Hapsburgs (since 1532) and the Prussians (since 1742). in June 1945 it reverted to become part of present-day Poland as a result of the Yalta agreement signed earlier that year. the lepman family came from in and around Kappel Grafenhausen, which is located in Baden-Wurtenberg, somewhat north of present-day Freiburg. Hans Walter Kosterlitz was the elder son of Bernard Kosterlitz and selma lepman.
Hans grew up in Berlin, where his father worked as a physician. at the time of his birth in 1903 the family lived at 21 thomasiusstrasse, situated just to the north of the zoological gardens. as a child Hans enjoyed and was adept at mathematics. He described a meeting with a stepdaughter of albert einstein, who lived nearby, and from her accounts Hans became impressed by the idea of a life in science. His father thought otherwise and recommended the study of law. Hans dutifully started this at the University of Berlin.
But after six months he transferred to his own choice of medicine, later citing the intellectual and career 'freedom' that it presented. He indeed took advantage of the freedom provided by the curriculum, and attended lectures in Heidelberg and Freiburg as well as Berlin. During his years as a clinical student, he found time to work in the laboratory of Peter rona, who was renowned for his development and application of biochemical techniques in enzymology. Hans later explained, 'i was given a key to the laboratory' and 'told not to break anything'. He also recounted that he 'never went home before midnight'. Peter rona had been a close colleague of leonor Michaelis during the period 1910-24. By choosing him as his first mentor, Hans followed a string of scholars later to gain distinction in biomedical sciences, notably Carbohydrate metabolism on graduation in 1928 he became an assistant in the First Department of Medicine at the University of Berlin. the head of this department was Wilhelm His, the swiss-born academic physician famous for his eponymous bundle that carries the electrical impulse from the atrioventricular node of the heart. Hans enjoyed the clinical work, and in due course he became head of the fever hospital. He also worked in the radiology department and was particularly enthusiastic about the new thin-layer barium methods for visualizing gastrointestinal pathology. Much later, he wistfully recalled his profound sadness at detecting a primary carcinoma of the stomach in an 18-year-old woman, a diagnosis initially derided by his senior colleagues, but later confirmed post mortem. in the evenings he would revert to the laboratory, the work here funded by his income from clinical radiology. His interest in carbohydrate metabolism was developing, and particularly the impediment shown by the failing liver to convert galactose into glucose, thus resulting in severe galactosaemia (1)*. He was particularly interested in the observation that diabetics could tolerate fructose and sorbitol better than glucose, results that he obtained by using the pancreatomized dog preparation that had been introduced by oskar Minkowski (elder brother of the famous mathematician). Galactose and glucose are enantiomers, differing only in the configuration of the hydroxyl group at carbon atom 4. Kosterlitz became stimulated to seek the mechanism that converted galactose to glucose (the Walden inversion).
Hans worked essentially alone during this period, although provided with facilities by the head of the department. Much of the work was published in a series of papers in Zeitschrift für die Gesamte Experimentelle Medizin (Z. Ges. Exp. Med.) in 1932-33 (2-5). Hans never divulged much about his personal feelings or circumstances throughout this turbulent time of developing fascist power. adolf Hitler became chancellor of Germany in February 1933, and * numbers in this form refer to the bibliography at the end of the text. on 7 april 1933 the law for the restoration of the Professional Civil service was passed. this called for all Jews working for the government (which included university staff) to be dismissed from their jobs (a similar law was later passed to cover all lawyers, doctors, tax consultants and notaries). the move to aberdeen By 1933 Hans had made contact both with John James rickard Macleod Frs (in aberdeen) and with Carl Cori (ForMemrs 1950) and Gerty Cori (in st louis). Macleod, who shared the 1923 nobel Prize in Physiology or Medicine for the discovery of insulin, had returned to scotland from toronto in 1929 to the regius Chair of Physiology. He had earlier studied medicine in aberdeen. Macleod was fluent in German and would have been well aware of Kosterlitz's early work. He wrote initially that he could 'offer little hope of being able to help' owing to lack of funds, and advised Hans to contact the academic assistance Council. the academic assistance Council, which was created on 24 May 1933 with the financial support of imperial Chemical industries (iCi), offered modest support. this was sufficient for Macleod to respond in september 1933: 'come to aberdeen … but no guarantee of a secure job'.
thus it was that when Hans Kosterlitz arrived in aberdeen in March 1934 he was living mostly on family savings. He sought to engage in clinical work and attended ward rounds, but this became untenable in the longer term. Macleod's laboratory was situated in Marischal College, a huge edifice near the city centre constructed from local silver-grey granite and described by John Betjeman as 'bigger than any cathedral, tower on tower, forests of pinnacles, a group of palatial buildings rivalled only by the Houses of Parliament.' Macleod introduced Kosterlitz's first paper in english (6) .
alas, Macleod was already suffering a debilitating illness, and his death on 16 March 1935 left the young Kosterlitz very much in scientific isolation. a few days later, Hans learned that he was to be awarded the first ever project grant (£50) from the Diabetic association (this is now Diabetes UK; the charity was established by r. D. lawrence and H. G. Wells in 1934). in 1937, he also received his first grant from the Medical research Council. on the personal side, the loneliness was assuaged by the arrival in scotland from Berlin of Johanna Maria Katherina Grosshöner (Hanna).
in Berlin, Hans's father, Bernhard, had served as the physician to a theatre, and had access to free tickets. Hanna worked at that time as an assistant in a clinical biochemistry laboratory. there was of course profound discouragement of any contact between Jews and aryans at the time, and family legends suggest that the availability of these tickets facilitated the initial relationship between Hans and Hanna. When she came to scotland in 1935 Hanna took up a role as nanny for the shanks family in Barrhead, near Glasgow. shanks was a worldwide name in the production of vitreous enamelled bathroom fittings. as Hans later described it: i visited her quite regularly, and she once or twice came to me, and then we decided we can't continue this way and even with the nazis, i was scared, first, if a Jew married a non-Jew, you are out, both of you, no problem. so we had to decide, finally decide, that we would never go back … and then we got married.
there are no known further references by Hans to his Jewish ancestry, and throughout his life he exhibited no evidence of following that or indeed any other faith. He also vowed to himself at this time never to speak again in German, and later would become visibly annoyed when well-meaning colleagues in British science would engage him in the language. in 1939 Hans's parents and brother rolf also relocated to england, where they settled in oxford. During the war years, both Hans and rolf were interned on the isle of Man for several months; the personal intervention of the Principal of the University of aberdeen (sir William Hamilton Fyfe) prevented Hanna from being interned.
During the late 1930s Kosterlitz returned to his earlier interest in why patients with liver failure developed galactosaemia. this led to the first synthesis of galactose 1-phosphate. By comparing the properties of this synthetic material with that of the substance extracted from the liver of galactose-fed rabbits, he was able to show conclusively that phosphorylation of galactose at the 1 position was the first step in its conversion to glucose (7, 8) , in what is now known as the leloir pathway. Hans became medically qualified in Britain (MrCs lrCP) after written and oral examinations, and was awarded a PhD (1936) from the University of aberdeen on the basis of a written thesis. in 1939 he was appointed lecturer in the Department of Physiology.
Proteins, nutrition and liver funCtion after the outbreak of war Hans sought more direct application for his research and entered the area of nutrition, favoured by the proximity of the rowett research institute. He quantified the effects of protein in the diet by microscopic and biochemical observations on liver cells, and this led to an assay for the nutritive value of protein (9, 10) . some of this work influenced guidelines for protein intake during pregnancy (11) . His devoted technician during this period (the 1940s) was rosa Campbell, but despite publications in Nature and Science he had considerable difficulty in finding continuing grant support for her employment. ian innes joined the laboratory in 1949. innes had graduated MB ChB from aberdeen in 1937, and initially worked for 10 years as a general practitioner. He joined Kosterlitz for some 'postgraduate training', but he became infected by Hans with the love for experiment and later abandoned medical practice. He moved to Winnipeg in 1958, serving as Head of the Pharmacology Department of the University of Manitoba from 1967 to 1982. the move to the autonomiC nervous system Further testimony to Kosterlitz's ability to inspire young people came from the experience of W. W. (Bill) Douglas (Frs 1983). Bill arrived in aberdeen from medical school in Glasgow in 1946, intending to train as a neurosurgeon. as a demonstrator in physiology, he would be able to prepare for his FrCs examinations. He put his surgical skills to good use by isolating the sinus nerve of the cat and measuring the vasomotor effects of electrical stimulation. a few years with the contagious zeal of Hans Kosterlitz resulted in Bill's giving up his surgery ambitions and embarking on a highly successful career as a physiologist and pharmacologist (ritchie 2000). the presence in the laboratory of Bill Douglas and ian innes sparked in Kosterlitz an interest in the innervation of the viscera that would sustain him for several decades.
Walter Cannon had found in 1922 that the diet could influence the properties of the sympathin released by stimulation of the hepatic nerves-of course, sympathin was not known to be noradrenaline at that time. Hans had hoped to find an interaction between dietary protein restriction and the effects of hepatic nerve stimulation, but he was not able to replicate Cannon's findings. this paper nonetheless marked the transition from an interest dominated by nutrition to one that focused on autonomic nerves (13) . Further papers at this time with innes and Douglas dealt with the vasomotor effects of stimulating the sinus and the vagus nerves, and the confounding effects of barbiturate anaesthesia (12) . By recording contractions of the nictitating membrane of the cat, he showed that denervation caused a selective increase in sensitivity to noradrenaline, whereas decentralization produced a more non-specific and generalized increased sensitivity to a range of amines (14) . a striking feature of this work was the effort to interpret the results in the context of the chemical structures of the amines used, with differences depending on the relative disposition of the hydroxyl groups on the catechol moiety. Perhaps this was unsurprising, given his background in understanding the critical role of the 4-hydroxyl conformation in sugar metabolism.
the logical place to pursue these developing interests in the pharmacology of the cardiovascular system was Harvard. From september 1953 to January 1954 Kosterlitz went on study leave with otto Krayer, with financial support from the Carnegie and Fulbright trusts. Kosterlitz knew Krayer from Berlin. Krayer had completed his MD at Freiburg, and moved to Berlin with Paul trendelenburg in 1927 when the latter assumed the Chair of Pharmacology there in 1927. When trendelenburg died in 1931, Krayer had been appointed professor at age 32 years. the story of Krayer's striking moral altruism would have been known by Kosterlitz at that time. Krayer had been asked to take over the Chair of Pharmacology in Dusseldorf in 1933, after the forced dismissal of the Jewish incumbent, Phillip erlinger. He wrote to the Prussian Minister of education stating that he was morally unable to succeed to the chair because he considered the expulsion of erlinger to be immoral and unjust. in reply, the government prohibited Krayer from entering any university premises, including university and state libraries. Krayer left Germany at the end of 1933, going first to University College london and then to the american University in Beirut, before moving to Harvard in 1937. By 1952 he was the pre-eminent cardiovascular pharmacologist, and in particular he was a master of starling's heart-lung preparation.
the subject matter of their joint research in Boston was the effect of veratrum alkaloids on the heart. Veratrum alkaloids had been used empirically to reduce blood pressure in pre-eclampsia, and one of Krayer's projects was to determine the mechanism of this effect. Kosterlitz found that veratramine acted at the sinoatrial node to cause a bizarre dysrhythmia, in which the cat's denervated heart would stop for several seconds before restoring normal sinus rhythm (15) . But there was a further lesson in these experiments. When Kosterlitz submitted the paper for publication, he was made aware by an anonymous referee of a similar experiment that had been performed 80 years before in Carl ludwig's laboratory (luciani 1873). He was henceforth quite intolerant of any literature gaps he detected in his own colleagues! first interest in oPiates Perhaps influenced by having overlooked the luciani paper, Kosterlitz began reading the literature with even more than his usual voracity. He noticed an old paper by Paul trendelenburg. this described that low concentrations of opium alkaloids inhibited the peristaltic reflex of the isolated ileum of the guinea-pig (trendelenburg 1917). in trendelenburg's experiments the threshold concentration of morphine was 1 part in 50 million, corresponding to 1 μg in a 20 ml solution (about 100 nM). in the mid 1950s Paton (Paton 1957 ) and schaumann (schaumann 1955) had reinvestigated these effects, using both electrical stimulation of the ileum and peristalsis evoked by distension. Back in aberdeen, and working particularly with Judith robinson, Kosterlitz studied this action of morphine on the isolated myenteric plexus-longitudinal muscle preparation (16) . this used Gaddum's dose-ratio approach to demonstrate antagonism by nalorphine and levallorphan (Gaddum et al. 1957) . in the course of this work he became an authority on the peristaltic reflex itself (17, 19) , through which the isolated ileum can respond to distension by a patterned discharge of intramural inhibitory and excitatory nerves to bring about the onward propulsion of its contents, and as a result he was invited to several major gastroenterology meetings. the pursuit and elaboration of this finding set the stage for much of his subsequent work, and resulted in his becoming known among less respectful colleagues by the sobriquet 'Mr Guinea Pig ileum'.
the predominant thinking at this time was that morphine simply 'anaesthetized' nerves, and that this was responsible for its pain-relieving actions. Hans Kosterlitz and his colleagues showed that with morphine this occurred only at higher concentrations, and that therapeutically relevant concentrations actually exerted their effect by inhibiting the release of neurotransmitters rather than by simply blocking their postsynaptic actions. Joined by Vivien Pirie, Douglass taylor, alan Cairnie, emman Gyang, David Wallis, Gordon lees and louise Cowie, he showed that the effect was observed at several neuroeffector junctions, was greatest at low frequencies of stimulation, and did not result from local anaesthetic action. not only was the release of acetylcholine inhibited, but also that of noradrenaline from the sympathetic nerves innervating the nictitating membrane of the cat.
Kosterlitz remained obsessed not only with the low concentrations of morphine that were effective, but with two further aspects. First, the effect of morphine was mimicked by levorphanol but not by dextrorphan-these two molecules are stereoenantiomers. second, nalorphine, which was a close structural analogue of morphine, often acted to block the effects of morphine. in 1962 he visited the national institutes of Health (niH) and met Julius axelrod (ForMemrs 1979) , then at the peak of his prowess for his discoveries on the metabolism of catecholamine transmitters. at the niH, axelrod introduced Hans to nathan eddy. nathan eddy studied heroin addicts undergoing withdrawal, and sought to determine the effectiveness of new opiate-like drugs to relieve their symptoms: this was then compared with the ability of the drugs as pain-killers in normal subjects. eddy had recently synthesized (with everette May) new benzomorphan analgesics with reduced capacity to cause dependence, and Kosterlitz regarded him as the 'undisputed nestor in the field of opiates' (25). Hans Kosterlitz next visited Harris isbell at the addiction research laboratory in lexington, Kentucky, to learn about his work with W. r. Martin on addicted prison inmates. Finally, he travelled to meet Maurice seevers at the University of Michigan, who worked with a colony of morphinedependent monkeys.
seevers was sceptical about Kosterlitz's results on peripheral nerves of lower animal species. after all, opiates exerted their actions in humans on their central nervous systems. He offered to provide Kosterlitz with a range of unknown compounds to test on the peripheral models, and asked whether their identity might be determined. With little hesitation, Kosterlitz agreed (25). in the following weeks, the eight coded compounds were dispatched to aberdeen and duly tested. Gordon lees performed the work on the cat nictitating membrane, and emman Gyang performed the studies on the guinea-pig ileum (18). Within three months all except one had been identified. Compound number 5 exhibited both agonist and antagonist properties, and it took some head-scratching and further discussion before this behaviour was identified as that of the partial agonist nalorphine (lees 1998). the remarkable correlation between the effectiveness of these eight compounds as analgesics in monkeys and humans, and their ability to inhibit transmitter release in preparations of two peripheral tissues, was more than nice science: it secured Kosterlitz a position of high repute among the american drug-addiction cognoscenti. Henceforth, the 'Mr Guinea Pig ileum' sobriquet was used with admiration.
By the mid 1960s naloxone became available. nalorphine was a partial agonist that was most widely used for its antagonist effects (i.e. to reverse the effect of excess morphine), but naloxone is a pure antagonist at opiate receptors. the implication that morphine itself was an agonist was not readily accepted by pharmacologists, and prevailing thought was that morphine blocked the actions of a transmitter (such as acetylcholine). the determination of its dissociation equilibrium constant by Kosterlitz and Watt (20) using schild analysis stands as a classic in the pharmacological literature. it also set the stage for the later discovery of distinct subtypes of opiate receptor.
Hans had lost the sight of his right eye in a shooting accident when he was 10 years old, and during the period 1963-66 he was progressively afflicted by cataract in his left eye. it seems possible that his exposure to radiation in his early career in clinical radiology might have been a causative factor. this reached the point at which he could no longer read, and for a period his colleagues, particularly Gordon lees, took on the role of surrogate literature scanners and read to him the most significant papers. in those days, cataract removal was by no means the routine procedure of today, and it was with much apprehension that he submitted to surgery in the autumn of 1967. Fortunately this was a great success, and he was soon back not only to reading but also to driving, with his usual vigour. there were many tales in the laboratory about his driving and minor skirmishes on the road, and these often seemed to involve other drivers failing to notice him. on those occasions on which a group of laboratory members would travel by car to another location, for a lecture or a dinner perhaps, there was generally a convivial rush by those without cars to join the vehicle of anyone who was driving other than Hans himself.
life at foresterhill in 1968, then aged 65 years, Kosterlitz became a professor, by his appointment to the newly created Chair of Pharmacology in aberdeen. this was long overdue: he had been elected to the royal society of edinburgh in 1950 and had for several years enjoyed grant support not only from the Medical research Council but also from the Usa. the delay reflected a long-lasting subliminal racial prejudice at the university, and the eventual promotion can be directly attributed to alistair MacGregor, regius Professor of Materia Medica, who fought to overcome lingering resentment. When he transformed his department to that of therapeutics and Pharmacology, he established within it the section of Pharmacology with Hans Kosterlitz as its professor. the section occupied newly refurbished space on the Foresterhill campus, which is the site of aberdeen's major hospitals, and about two miles from Marischal College. Most significantly, it allowed Kosterlitz to oversee three new appointments in the discipline of pharmacology.
First, Gordon lees, a long-term collaborator and confidant, was prevailed upon to move from the Department of Physiology at Marischal College to Foresterhill, where he set up an electrophysiology laboratory. second, Kosterlitz was visiting Yale University in 1968 and had met John Hughes at the instigation of John (later sir John) Vane (Frs 1974). they struck up an immediate rapport and soon established their common interest in the factors that control synaptic transmission, although Hughes had little interest in opiates at that time. Hughes was persuaded to join Kosterlitz as lecturer in Pharmacology in 1969, in preference to an offered appointment at Kings College, london. third, John Gilbert joined a year later as lecturer in Biochemical Pharmacology. in 1971 Pharmacology became a separate university department and began teaching undergraduate degree programmes, with Hans Kosterlitz at its head.
the belated recognition by the University of aberdeen was in stark contrast to the esteem in which Kosterlitz was now held by his international colleagues. one measure of this was his leading role in the establishment of the international narcotics research Club (inrC). Jointly with Harry Collier, he organized a half-day satellite symposium in Basel on 19 July 1969, after the Congress of the international Union of Pharmacology. Most reports seem to focus on the luncheon and the wine provided at the Hotel euler: Harry Collier, syd archer and Hans Kosterlitz were certainly convivial gourmets. Maurice seevers chaired the meeting, and the other speakers comprised a constellation of international opiate aficionados (sydney archer, arnold Becket, Geoffrey Blane, avram Goldstein, lou Harris, Gordon lees, Cyril schneider, Julian Villareal and eddy Way). the inrC has met annually ever since its first meeting in aberdeen in 1971, at more than 35 locations in a dozen different countries, and remains the premier scientific meeting for the presentation and discussion of new findings in opiate research. in the mid 1970s the name underwent a minor mutation to international narcotics research Conference, when political correctness suggested that this might meet with more favour from granting agencies (who have continued to support the meeting). However, the atmosphere of the meeting remains more 'club-like' and informal than that found at most other large international conferences.
our view of the opiate receptor at that time was very much based on the stereoselectivity exhibited by morphine analogues, and by the competitive antagonism with naloxone that had been so elegantly demonstrated by Kosterlitz and his colleagues. their work had swept away much of the confusion surrounding the primary mode of action of morphine, which had been variously thought to be a membrane stabilizer, receptor blocker, 'physiological antagonist' or even enzyme inhibitor. it was clear that morphine was an agonist, requiring an interaction with its membrane-bound receptor to initiate a secondary chain of biochemical events within its target cell. the target cell in the guinea-pig ileum was thought to be the cholinergic neuron, and this agreed with other evidence linking morphine and cholinergic systems. However, the effects on the cat nictitating membrane indicated that morphine could similarly affect noradrenergic nerves. as for the receptor itself, Beckett & Casy (1954) had posited a flat surface to accommodate the aromatic moiety of morphine's a ring with its phenolic hydroxyl, and this was separated by a small cavity from the anionic site that bound morphine's quaternary nitrogen atom. somehow, the attachment of an unsaturated substituent to morphine's quaternary nitrogen atom (as in naloxone) produced an antagonist. the remarkable ability of in vitro tissues to predict the in vivo analgesic effectiveness of opiate analogues had now been shown over five log units of potency (22) .
in the early 1970s the development of receptor binding protocols added a new technique to the pharmacologist's armoury. Pedro Cuatrecasas (Cuatrecasas 1971 ) and Humphrey rang (Frs 1980) (Paton & rang 1965 ) had used radioactive ligands to identify binding sites for insulin and muscarinic drugs, and various laboratories were making strenuous efforts to radiolabel the opiate receptor. Morphine itself was a poor ligand, having a relatively low affinity and high non-specific binding; however, the highly potent agonist etorphine and the antagonist naloxone soon became available in tritiated form with high specific radioactivity, thus providing key tools. opiate actions were known to be produced preferentially by the (−)-conformer of entantiomers, and it was demonstrated that the binding, or displacement, of these radioactive ligands to brain synaptic membranes was also stereoselective (simon et al. 1973; Pert & snyder 1973; terenius 1973 ). a cultural divide became apparent between the classically trained British pharmacologists and the americans: the latter equated the binding site with receptor, whereas the British defined the receptor on the basis of functional consequences. the issue was loudly exemplified when one american laboratory held a press conference to claim that they had 'discovered' the opiate receptor. of course, Hans was fully entitled to use the word receptor as mediating his effects: he felt that the others were entitled to use the term 'binding site'. But it is fair to say that this distinction proved too subtle for many! one of the traditions that had been established in the new Department of Pharmacology was the presentation of seminars by the staff, graduate students and visiting scientists. these were informal affairs but conducted with intellectual vigour, with Hans in the forefront of any discussion. at one such meeting early in 1972, Kosterlitz summarized the compelling data that indicated the highly significant correlation between the potency of opiate drugs, whether rank-ordered by analgesic efficacy or by inhibition of cholinergic neurotransmission in the guinea-pig intestine. there followed an animated discussion about the significance of these observations that, while familiar to most in the room, still left open a variety of interpretations. the 'Prof' argued forcibly that such a stereospecific receptor must have a physiological function and be coupled to an intracellular effector mechanism. examples of other plant alkaloids that could activate other endogenous receptor systems were well known. they included muscarine and nicotine on different acetylcholine receptors. the logic of the argument was difficult to resist: morphine and its congeners were agonists at an endogenous physiological receptor and therefore the body must produce an endogenous morphine-like factor! the seminar broke up with most participants agreeing that if such a substance existed it would be extremely difficult to detect. an obvious approach would be to make tissue extracts and test them on the guinea-pig ileum for inhibition of cholinergic transmission. the advantage of a bioassay would be that any inhibition caused by the putative morphine-like factor should be blocked by naloxone, thus providing a vital check for specificity of action. there were two major problems to address. First, the guinea-pig ileum is exquisitely sensitive to a wide range of biologically active compounds. second, what tissue and method of extraction should be used in the search? Kosterlitz was very doubtful that these difficulties could be overcome; some very tentative experiments with simple extracts of brain in aqueous ethanol (using borrowed guinea-pig myenteric plexus preparations at the end of an 'official' experiment) merely confirmed the seemingly impossible nature of the task.
the matter might have lapsed had it not been for two developments. the first of these was that Graeme Henderson and John Hughes (Frs 1993) had discovered a new bioassay for opiate activity (21) . Graeme was performing research for his PhD under the joint supervision of Kosterlitz and Hughes. His studies had already confirmed that the noradrenergic innervation in the nictitating membrane isolated from the cat could be inhibited by opiates, acting on a receptor apparently identical to the one in the guinea-pig ileum preparation. Kosterlitz was delighted at this result, because it confirmed his view that opiate action was not invariably associated with cholinergic innervation, as others had suggested. the result also strengthened the argument that opiate receptors could be widely distributed and had a significant physiological role. it was quickly realized that the nictitating membrane preparation, involving a long and delicate dissection, was unsuitable for the long-term studies required to identify any endogenous ligand. the search for another adrenergic bioassay finally led to a vas deferens preparation isolated from the mouse.
initial experiments confirmed that single contractions of the vas deferens elicited by stimulation of the intramural sympathetic nerves were inhibited by opiates in a naloxonereversible manner. it was established that, similarly to the guinea-pig ileum, inhibition of single twitches by opiates showed a rank order of potency parallel to their rank order of potency as analgesics. the opiate receptor in the vas deferens was linked to inhibition of noradrenaline release and seemed to be pharmacologically identical with that in the guineapig ileum. this was later to prove a serendipitous simplification in three ways. the effectiveness of morphine depends strongly on the strain of mouse, and some persistence paid off in finding the C57 black strain as the appropriate one. the muscle contraction or twitch actually results from the release of adenosine 5′-triphosphate rather than noradrenaline. And a later more detailed pharmacological analysis showed that the receptor was in fact distinct from the receptor of the guinea-pig ileum.
the second key factor was Kosterlitz's impending retirement: the University of aberdeen required him to retire, as he had reached the age of 70 years. sensing Hughes's frustration at the teaching load required of a lecturer, Kosterlitz proposed that he join him as his deputy in the new research unit he was planning on his retirement. Kosterlitz had approached the Us national institute on Drug abuse and the UK Medical research Council, which indicated that they were prepared to fund a new research group. in 1973 the University of aberdeen supported the establishment of the Unit for research on addictive Drugs (UraD), located close to the departments of Biochemistry and Physiology at Marischal College. Hans thus returned to the same building in which he had spent his entire career from 1934 to 1968. the university also agreed to the secondment of John Hughes to work in UraD, and relieved him of most of his teaching duties. the national institute of Drug abuse and the Medical research Council awarded grants that supported the work of UraD. the research plan adopted by Kosterlitz and Hughes envisaged that the major effort would focus on the mechanisms underlying opiate tolerance and dependence, using the various models developed at Foresterhill. Kosterlitz also, rather reluctantly, agreed that Hughes would continue tests to try to detect the putative endogenous morphine-like factor. But this did not form part of any plan submitted to the various grant bodies. the space provided by the university was old and dilapidated, so old that all the obsolete power sockets (designed by the defunct northern electric Power Company) were incompatible with the plugs on the instruments. lack of money precluded rewiring, so the new tenants scoured the university for discarded northern electric plugs, which were then attached to modern extension boards into which all the equipment was connected. However, once the very large rooms (5 m high) had been cleaned, the space proved serviceable, if rather draughty and noisy. academic visitors from abroad often found it difficult to understand how work of such importance could have been performed in such primitive circumstances.
disCovery of endogenous oPioids
Before moving from Foresterhill, Hughes had made a series of initial tests on aqueous alcoholic extracts of whole rat and guinea-pig brain-dried extracts, reconstituted in saline. When these extracts were tested on the guinea-pig ileum the tissue usually went into spasm, making any further measurements impossible; in contrast, at sufficient dilution, the same extracts slightly raised the baseline of the mouse vas deferens but also caused a complete inhibition of the contractions. the vas deferens was clearly a better assay system but the vital test, reversal of the inhibition by naloxone, was negative; occasionally, the addition of naloxone caused a small but brief increase in contractions, but Kosterlitz insisted that this was insignificant and that only a full reversal of the inhibition would convince him of the validity of the effect.
the samples were stored in a refrigerator and were moved to Marischal College with all the other laboratory apparatus. later, in the summer of 1973, Hughes decided to test the extracts one more time before removing them to make space for new samples. the extracts had lost some of their inhibitory potency during storage but, to the astonishment of Hughes and Kosterlitz, the inhibitions could now be reliably, if partly, reversed by naloxone. the excitement was palpable. it had become possible to probe the nature of the material and validate its pharmacology, although Kosterlitz's gold standard of complete reversal by naloxone remained to be attained. Cognisant of Beckett & Casy's work, Kosterlitz proposed that Hughes should test the stereospecificity of the antagonist reversal, using a benzomorphan antagonist (Mr2267) for which the two enantiomers had been resolved.
The result was clear-cut: the (−)-isomer reversed the inhibition but the (+)-isomer was inactive, exactly as would be expected if this were a true interaction with an opiate receptor. these events illustrate the unique nature of the collaboration between Kosterlitz and Hughes: Kosterlitz provided the essential pharmacological tools through knowledge of the literature and his pharmaceutical contacts, and also acted as a stern critic by insisting that rigorous conditions must be met before the results could be accepted. Hughes provided youthful energy (he was 31 years old at this time) and the necessary biochemical expertise. a series of biochemical tests on the still crude extract established that the active material was a small peptide with a molecular mass of less than 1500 daltons. it could be further purified by gel and resin chromatography so that the naloxone reversal now approached 100%. the material was also found to be highly concentrated in the globus pallidus/striatal area of the brain.
an alternative source of brain material was required for large-scale purification. in 1973 the abattoir of aberdeen city was a forbidding place and was overdue for demolition. its Dickensian ambience was enhanced by first impressions of the staff: strong, rough-voiced men who accompanied their butchering with tales of the previous night's exploits in aberdeen's more dubious harbour-side nightspots. if Hughes was taken aback by these surroundings, the abattoir staff were equally bemused by this scientist from a totally alien world; however, they proved sympathetic and agreed to provide a workbench and one pig head in six as they came off the conveyor line. to compensate for any disruption caused by his activities, Hughes produced a bottle of scotch, provided by Kosterlitz. Hughes dissected the brains in the abattoir to isolate the striatum, which was immediately frozen on solid Co 2 . on his return to the laboratory he pounded the frozen brain fragment with a heavy stainless steel bar to produce a fine powder, which could then be extracted with an acetone/acid mixture. this procedure minimized any proteolysis and provided a solution that could be readily concentrated, an important factor because the extraction involved tens of litres of solvent, and this soon progressed to semi-industrial quantities as the number of brains approached 200.
John Hughes usually dropped into the Prof's office at the end of the day to discuss progress on the various projects, but one morning, soon after the large-scale extraction had begun, an agitated Kosterlitz met Hughes as he returned from the abattoir. a very angry lawrence Malcolm, Professor of Physiology, had complained that the pulverization procedure was making his life intolerable; the vibrations, amplified by the ancient wooden beamed floors, were directly above his office. the solution was not a pleasant one; the only place with a solid floor was the gentlemen's toilet in the basement and so Hughes was banished there for the initial extractions.
the develoPing ComPetition in september 1973 Kosterlitz attended a planning session for a forthcoming meeting of the neurosciences research Programme (nrP) in Boston. on his return, he excitedly announced that Hughes would be invited to be one of the speakers. the reason for this was that Kosterlitz had revealed that Hughes had good evidence for an endogenous opiate. Hughes was furious. although the work was going well, he knew from his experiences at Yale that the americans could be intensely competitive, and that premature disclosure might cost them the prize of being first. Kosterlitz had been brought up in the British tradition of open discussion, typified by the meetings of the Physiological society and British Pharmacological society. although attitudes in Britain were changing, the 'gentleman scientist' Kosterlitz was somewhat slow to realize that competition for grants and glory might eclipse the forthright cooperative academic tradition. Hughes's misgivings were not unreasonable as it turned out, but in the short term the upcoming meeting acted as further stimulus to the research programme and the preparation of the first scientific publication.
the nrP discussion meeting took place on 19-21 May 1974 at a historic country house (the Brandegee estate) on the Brookline-Boston border. it was attended by the leading lights of opiate research, among whom were avram Goldstein, eric simon, lars terenius and solomoin (sol) snyder. the main discussion focused on opiate receptor pharmacology and particularly on the new data arising from studies of opiate receptor binding. However, there were several ancillary speakers, including Huda akil. she presented the most compelling physiological results for an endogenous opioid system. Working with John liebeskind she had found that electrical stimulation of the brain periaqueductal region elicited a reduced response to painful stimuli in the rat; critically, this analgesic state could be abolished by naloxone. Kosterlitz was delighted by this result, because he had become renowned for asking researchers making any claims regarding an effect of morphine whether they had checked its reversibility by naloxone. this was his sine qua non for an effect mediated by opiate receptors. this report that naloxone was working in the absence of any applied exogenous morphine was strong evidence for the existence of an endogenous opioid agonist at the behavioural level.
Hughes was subjected to intense questioning after his presentation and, with Kosterlitz's support, avoided answering detailed technical questions as best he could. However, akil and Hughes had clearly said enough to convince most participants, and some more than others. to add to the tension, lars terenius described preliminary evidence for a morphine-like factor in brain extracts as detected by an opiate receptor-binding assay.
Competition was thus fierce but the aberdeen laboratory held two advantages, and they were already in the analytical phase of their work. First, collaboration with the peptide chemist Barry Morgan allowed the team to use the pilot plant at his company (reckitt & Colman) in Hull to perform extractions on some 500 pig brains. this was essential because it had become impossible to handle safely the very large volumes of acetone solvent that had to be evaporated. second, and more importantly, the use of two bioassays (the purified material produced naloxone-reversible inhibition in both the mouse vas deferens and the guinea-pig myenteric plexus preparations) proved incontrovertibly that they were dealing with an opioid. Competitors using the binding of radioactive ligands could have less confidence, but it later transpired that they redoubled their efforts in view of the impetus provided by the results from aberdeen.
a first paper was ready to be submitted to Brain Research by late 1974. Hughes had written the manuscript detailing the purification and pharmacological and chemical properties of the still unsequenced oligopeptide, and with Kosterlitz's help he had completed the final draft. it was at this stage that Kosterlitz, to Hughes's surprise, removed his name from the paper, explaining that he felt that his young collaborator deserved the full recognition for his work. it was a magnanimous gesture on the part of Kosterlitz, although incorrectly interpreted by some that Kosterlitz wanted to distance himself from the work! indeed, a further rumour reached aberdeen that Kosterlitz and Hughes were actually working independently of each other! the paper was published in May 1975 (Hughes 1975) . the paper names the endogenous opioid only as substance X, but in aberdeen discussion had already led to the decision that it should be known as enkephalin (from έγκέφαλος, 'within the head').
the 1975 meeting of the inrC was held in May, at airlie House in the Virginia countryside. there was much tension and the clear sense that the main players were not revealing all the details of their progress towards the identification of the endogenous opioid. the question of nomenclature arose, and a splinter meeting organized after the main conference included some heated arguments over naming rights. Kosterlitz defended his decision to follow precedents in physiology and endocrinology by naming after the organ of origin, and he was resolutely opposed to ascribing any function to the new peptides. others had different ideas, and some were anxious to be associated with the discovery by having their pet names adopted. once again, the harmony of the opiate community and the inrC was threatened by a serious discord that had been only narrowly averted after the nrP meeting. this time Hans was in no mood to compromise, and in concert with Hughes he announced their decision to use enkephalin. the group then agreed that the generic name for all endogenous peptides should be endorphins but that investigators were entitled to name individually discovered peptides. it was not an entirely satisfactory solution, but the term endorphin has entered popular parlance. β-Endorphin (derived from β-lipotropin) is the major circulating opioid hormone, and the enkephalins are neuronal messengers in both the central nervous system and the gastrointestinal tract.
also in the spring of 1975, terry smith joined the isolation and purification effort, and linda Fothergill from the Department of Biochemistry in aberdeen had begun sequencing of the peptide chain by edman degradation. But a further key member was about to join the collaboration. leslie iversen (Frs 1980), who had attended the Boston nrP meeting, had invited Hughes to give a seminar in Cambridge, where he directed the Medical research Council's neurochemical Pharmacology Unit. at the conclusion of the seminar Hughes was approached by Howard Morris (Frs 1988) , from the Department of Chemistry, who offered his assistance with the sequencing of the peptide. Morris had pioneered the technique of protein sequencing by mass spectrometry; he emphasized that he only required milligram quantities and could deal with mixtures or even impurities. this created a dilemma in view of the continuing collaboration with Fothergill; however, edman sequencing had given an ambiguous result and Fothergill was relaxed about involving Morris. another batch of pig striata was processed and purified, and the new technique of high-performance liquid chromatography proved invaluable in the final stage, yielding a single, apparently homogeneous, ultraviolet absorption peak. Kosterlitz urged Hughes to take the purified sample personally to Cambridge and hand it safely to Morris. a week later Morris telephoned with the news that he had sequenced not one but two pentapeptides: they had the common amino-terminal sequence tyr-Gly-Gly-Phe-but differed in having Met or leu in the fifth position. the mystery of the ambiguous sequence was solved: the two peptides were extremely difficult to separate and only the mass spectrometry could provide an unambiguous result. these peptides were named Met-enkephalin and leu-enkephalin.
Barry Morgan rapidly synthesized the enkephalin peptides and brought them to aberdeen. the team was jubilant. Both pentapeptides were potent opiate agonists in the mouse vas deferens and guinea-pig myenteric plexus preparations. a paper for Nature was in preparation when Hughes took a call from Morris. He excitedly announced that he had just attended a seminar by Derek smyth of the national institute of Medical research at Mill Hill. smyth had shown the structure of β-lipotropin, a 91-amino acid pituitary protein of unknown function. Morris immediately recognized the Met-enkephalin pentapeptide sequence embedded within the sequence of the pituitary protein. this remarkably fortuitous observation was included in the Nature paper, which was published on 18 December 1975 (23) . it eventually transpired that β-lipotropin was not, as the Kosterlitz team had initially suspected, a precursor for Met-enkephalin; rather, it was the precursor of another larger opioid hormone later termed β-endorphin. However, the floodgates had been opened by the identification of the enkephalin and β-endorphin sequences. a tsunami of papers followed, describing new opioid peptide sequences in the brain and pituitary. these included descriptions, first for the protein and then for the gene, of not one but three opioid peptides (enkephalin, dynorphin and β-endorphin). All of these have an aminoterminal tyrosine residue and are inactive when this is replaced by phenylalanine. it is easy to overlay the tyrosine structure onto that of morphine: the nitrogen atoms coincide, and the benzene ring occupies the obligate a ring of morphine. the criticality of the hydroxyl group of the tyrosine agrees with the well-known observation that in morphine the hydroxyl group at position 3 is also essential for activity.
throughout the period from 1975, a steady stream of research data was emerging from the UraD laboratories. Kosterlitz had embraced the technique of receptor binding with his customary thoroughness, and allied with new data from the bioassays he had evinced clear evidence for the existence of multiple opiate receptors. Hans admired the compelling conclusions provided by Bill Martin's work on morphine-dependent monkeys. this indicated a distinct receptor activated by ketocyclazocines at which morphine was relatively weak; it was termed the κ-opiate receptor. Kosterlitz's team carefully measured the number of binding sites occupied by a variety of radiolabelled ligands and the displacement caused by an even greater variety of unlabelled ligands. the data pointed to the existence of at least three separate binding sites. together with John lord and angela Waterfield he showed that although naloxone antagonized the effect of ketocyclazocine, it required a concentration some three to five times higher than was needed to block the action of morphine. Moreover, Kosterlitz and Hughes had discovered that inhibition of the vas deferens contraction by enkephalin was 20 times less sensitive to reversal by naloxone than was a similar inhibition produced by morphine, but there was no difference in antagonist potency when tested on the guinea-pig myenteric plexus. in a 1977 Nature paper they defined two opioid receptors (μ and δ) both as binding sites in the brain and functional receptors in the mouse vas deferens and guinea-pig ileum (24) . The prevalence of δ receptors in the mouse vas deferens explained why naloxone was less effective in this tissue, whereas the μ receptor predominated in the guinea-pig ileum. The work also made clear that these receptors were both distinct from the κ receptor identified by Martin (26).
these were astonishing achievements for a 75-year-old retired professor in a rather remote university. Kosterlitz's enthusiasm never wavered but, inevitably and as he himself had predicted, other research groups gained prominence as immunohistochemistry, electrophysiology and molecular biology provided new tools for probing opioid peptide physiology. among the honours accorded to Kosterlitz was the 1978 lasker award for Basic Medical science, shared with John Hughes and solomon snyder. this award was the subject of criticism by one of snyder's postgraduate students, Candace Pert (Pert & snyder 1973) . it was suggested that she had been omitted from the prize because she was a student, and there were gender-based overtones. the incident was certainly reflective of the passions that were aroused in this highly competitive and prestigious field. Kosterlitz behaved throughout this controversy as a slightly bemused but consummate gentleman. Perhaps the incident influenced the nobel Prize committee, noted for its avoidance of controversy.
although he continued to work in UraD at Marischal College into his eighties, Hans's role had evolved to that of elder statesman in the opiate field. He was showered with awards and travelled extensively as an invited speaker at universities throughout the world as well as at the inrC and other international conferences. His stamina was legendary. a PhD student in Melbourne has recounted how, in 1977 (when he was 74 years old), she was asked to join her professor with some staff to have dinner with Hans Kosterlitz. it was during a visit that he was making to their university. He had arrived from scotland just hours before; he matched australian colleagues drink for drink, and yet was he making animated and thoughtful suggestions about research until well after midnight. His election to the Fellowship of the royal society at the age of 75 years marked a personal apogee for his academic career, but this imposed additional demands as a referee and committee member. together with John Hughes he also founded and become joint chief editor of the journal Neuropeptides, although he resigned after a year as the demands on his time became even greater. the discovery of the enkephalins had stimulated an explosion of interest in the neurobiology of brain peptides, and several more were being discovered each year.
indeed, some 20 years later (1995) a fourth opioid peptide was found to be encoded by the human genome: this is known as nociceptin or orphanin-FQ. Here, the amino-terminal residues are Phe-Gly-Gly-Phe-rather than the tyr-Gly-Gly-Phe-found in the enkephalins. lacking the critical hydroxyl group on the n-terminal residue, this peptide has little action at μ, δ or κ receptors, but instead it acts at a fourth receptor in the family (the nociceptin or ORL1 receptor). its actions are also very insensitive to naloxone, and on this account it surely would have been deemed not worthy of attention by Hans Kosterlitz! Few researchers live such a long and productive professional life as did Kosterlitz. apart from his long list of original contributions, he remained a committed teacher and fostered the careers of his students and collaborators, and many of them went on to attain significant positions in academia and industry. Despite several bouts of serious illness in his late eighties he continued to travel abroad to meetings with his wife, Hanna, until his deteriorating health finally confined him to his home village of Cults. after his death in 1996 it was fitting that he was committed by family and former colleagues in a windswept cemetery at newhills, overlooking his adopted city of aberdeen.
Personal reColleCtions: alan north My first exposure to Hans Kosterlitz came as one of 70 medical students in a lecture hall, listening to his efforts to make the autonomic nervous system seem interesting to future doctors. like others before and since, he failed. But when i came to intercalate a one-year programme of study leading to a Bsc in physiology (in 1964/65) my impressions became quite different. twice each week there were day-long practical classes, typically with in vivo or in vitro tissue experiments performed by the students, in a converted garret under the roof of Marischal College. Hans supervised several of these. He was always particularly interested in, and seemed envious of, the fact that i was also able to take physics classes at the same time. He had a facility and enthusiasm for any mathematical description of the experimental results, and it was only some years later that i discovered that he had always regarded his choice to study medicine as second best to physics. some years later i rejoined his new department to undertake experiments leading to a PhD, and then again went back to UraD briefly as a postdoctoral fellow. now i learned that his passion for discovery was remarkably offset by his sense of humour. He was always ready for an eye-twinkling challenge. at one stage i had a small sports car and, because i lived quite close to him, sometimes i would give him a ride home. He appreciated the mischievous way in which i would park close to the high kerb outside his house, so that as he emerged from the car he found himself, a 70-year-old, crawling on hands and knees on the adjacent pavement. He had adopted that peculiarly British manner through which a certain exhibition of 'lack of respect' stops just at the point that it transpires into ultimate respect. throughout this period (1965-75) his hospitality was legendary. His small house in Cults witnessed many an impoverished PhD student or postdoctoral fellow enjoying his first experience of smoked scottish salmon, or a good malt whisky. in this, Hans was hugely supported by Hanna, and their generosity extended through subsequent years, when i often met him for a superb meal-sometimes in association with a scientific meeting, but also when i happened to be passing by one of their personal holidays in north italy, the swiss oberland or the German Black Forest.
Hans enjoyed nothing more than a robust argument in which the jousting was always more significant than the victory. He dismissed those who did not defend their views, and became frustrated by others who could not follow his own thought processes. But such dismissals and frustrations were rarely apparent on the outside: politeness and humility always prevailed in his dealings with others. Hans became well known by his colleagues for his aphorism 'a day not spent in the lab is a wasted day.' in a way, this was a simple exemplar of his admonition to 'work hard, play hard.' But it was also his way of saying that if you do not constantly watch and probe nature, and carefully and cleverly too, then you cannot expect nature to yield much to you. (Frs 1976) . ritchie himself hailed from aberdeen and had recently become chairman of the department at Yale. the meeting was most convivial; the common interest in the pharmacological modulation of nerve transmission ensured an easy conversation as readily as did the bottle of malt whisky that Kosterlitz had presented to ritchie.
Kosterlitz speculated as to whether the mechanism of morphine inhibition of cholinergic transmission involved an action via sodium channels. ritchie agreed that this was possible and talked enthusiastically about his work on the interaction of local anaesthetics with axonal sodium channels. i was impressed by the easy manner of these two eminent pharmacologists, one a native and the other an adopted aberdonian. Kosterlitz showed considerable interest in our work in Bob roth's laboratory. Margaret Boadle, Bob roth and i had found that angiotensin facilitated both the release and synthesis of noradrenaline, and Kosterlitz was eager to discuss possible mechanisms underlying the control of synaptic transmission. His favourite expression was 'we need to understand what goes on in the black box'; then he would add, 'but we don't have the tools.' Kosterlitz's visit was followed by a letter that offered me a lectureship in his new department at aberdeen. the offer of a permanent job was certainly attractive. on first impressions, Kosterlitz was a rather forbidding figure with his formal manner, strong German accent and usual dark-suited attire. i would have jibbed at accepting any position at such a remote location had it not been for Kosterlitz's enthusiasm and the rapport that we had established in our brief encounter.
the academic world of 1969 aberdeen would be unrecognizable to those now embarking on a university career. Money was always short and facilities were well below the standard of equivalent american institutions. However, there was a freedom to conduct independent work and, given a good head of department, the opportunity to pursue novel ideas. Kosterlitz assigned me a laboratory and an attached office overlooking the leafy Foresterhill site, with a distant view of the sea. More importantly, i was provided with the services of a young technician (Helen anderson) and a six-channel polygraph recorder and other associated equipment. Helen was a no-nonsense aberdonian who quietly and competently learned the necessary assays and proved to be an invaluable assistant. other vital areas of support were access to excellent glassblowing facilities that supplied us with the necessary chromatographic columns for separating and measuring biogenic amines, and thermostatically controlled tissue baths for the bioassay studies. thus, in a very short time, i was able to establish my research with the support of Kosterlitz and the university. the generosity and kindness that was shown to me on arriving in aberdeen was something that i never forgot.
Hans, through his contacts with pharmaceutical companies, had acquired a discretionary fund that he used to support the purchase of equipment not funded by grants or the university. He also used this money to fund dinners for visiting lecturers, to which he also invited his staff. these evenings were delightful affairs. Hans's love of good food and wine was legendary, and with heated discussion of pharmacological problems this combined to develop an esprit de corps in the department. i should also mention that the Kosterlitz 'slush' fund came in most useful when we needed to thank the slaughterhouse men for their assistance with obtaining pig brains; a bottle of good malt whisky secures great favours in aberdeen! i had the good fortune to work with a man to whom scientific method and truth was paramount; lesser men in his position would have insisted that i should contribute to his own chosen field of opiate research, but Kosterlitz wanted a department with a spread of research projects. that is not to say that he did not try to influence my interests more subtly, and of course in the end he was successful in moving my attention to opioids! our convergence of interests came about through a process of argument and counter-argument over coffee and tea breaks, after-work drinks or just casual meetings. People visited each other's laboratory to discuss the latest results, and Kosterlitz was always ready with his interpretation of the data! i was sometimes saddened in later years after leaving aberdeen to find that researchers tended to keep to themselves and not to share their data with colleagues. this competitive and secret element was foreign to Hans Kosterlitz.
Hans and Hanna Kosterlitz were the kindest and most hospitable of couples and it was always a pleasure to visit their house in Cults, and on occasion be invited to share Christmas dinner with them. We often travelled as a trio to foreign meetings and invariably i was the first to tire as we attended yet another late meal at our destination. in later years even Hans's formidable stamina suffered on account of some episodes of transient cerebral ischaemia, but he still insisted on participating in overseas meetings. this could sometimes lead to unexpected consequences, as on a visit to Brussels where we were to receive the lucien Dautreband Prize. at Heathrow airport it was clear that Kosterlitz was unfit to travel, but Hanna and i were unable to dissuade him. it was agreed that i would speak for both of us at the meeting. all went well until the reception after the awards ceremony. Here, the King of Belgium approached Kosterlitz and inquired as to his future plans. Hans, very serious, paused, looked at his watch and replied 'twelve o'clock' in a very loud voice. the King was somewhat taken aback but quickly regained his composure, congratulated Kosterlitz and moved on.
i am proud to have been associated with Hans Kosterlitz. Most men, in his position, having faced the difficulties that he had in his career, would have retired at the age of 65 years. Yet he took on the challenges of establishing a new teaching department and then five years later a new research institute. His enthusiasm for life carried you with him even to the end. referenCes to other authors
